Luisa Ojeda‐Fernández

872 total citations
23 papers, 396 citations indexed

About

Luisa Ojeda‐Fernández is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Luisa Ojeda‐Fernández has authored 23 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in Luisa Ojeda‐Fernández's work include Vascular Anomalies and Treatments (8 papers), Tracheal and airway disorders (5 papers) and COVID-19 Clinical Research Studies (4 papers). Luisa Ojeda‐Fernández is often cited by papers focused on Vascular Anomalies and Treatments (8 papers), Tracheal and airway disorders (5 papers) and COVID-19 Clinical Research Studies (4 papers). Luisa Ojeda‐Fernández collaborates with scholars based in Italy, Spain and United States. Luisa Ojeda‐Fernández's co-authors include Luisa M. Botella, Carmelo Bernabéu, Lucía Recio-Poveda, Francisco J. Blanco, Eunate Gallardo‐Vara, Mikel Aristorena, Mateo de las Casas-Engel, Ángel L. Corbí, Roberto Zarrabeitia and Virginia Albiñana and has published in prestigious journals such as Journal of Cell Science, International Journal of Molecular Sciences and PLoS Genetics.

In The Last Decade

Luisa Ojeda‐Fernández

20 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa Ojeda‐Fernández Italy	13	140	119	96	70	54	23	396
Michael Scarpatetti Austria	11	132 0.9×	80 0.7×	74 0.8×	51 0.7×	7 0.1×	19	370
Mei Guo China	12	213 1.5×	59 0.5×	95 1.0×	84 1.2×	7 0.1×	40	530
Jennifer L. Oliveira United States	16	286 2.0×	209 1.8×	108 1.1×	27 0.4×	9 0.2×	59	748
N Gould United States	7	18 0.1×	109 0.9×	64 0.7×	92 1.3×	47 0.9×	10	373
Céline Bouvy Belgium	13	57 0.4×	25 0.2×	153 1.6×	17 0.2×	22 0.4×	30	421
Byung‐Kiu Park South Korea	10	32 0.2×	69 0.6×	92 1.0×	102 1.5×	8 0.1×	24	362
Madhu Rajeshwari India	9	76 0.5×	56 0.5×	62 0.6×	46 0.7×	13 0.2×	34	243
Yoshihisa Morishita Japan	12	71 0.5×	31 0.3×	104 1.1×	53 0.8×	23 0.4×	36	414
Laura D. Healy United States	12	95 0.7×	45 0.4×	123 1.3×	22 0.3×	13 0.2×	15	442
Laurentia Nodit United States	11	51 0.4×	112 0.9×	70 0.7×	217 3.1×	11 0.2×	40	471

Countries citing papers authored by Luisa Ojeda‐Fernández

Since Specialization

Citations

This map shows the geographic impact of Luisa Ojeda‐Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Ojeda‐Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Ojeda‐Fernández more than expected).

Fields of papers citing papers by Luisa Ojeda‐Fernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Ojeda‐Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Ojeda‐Fernández. The network helps show where Luisa Ojeda‐Fernández may publish in the future.

Co-authorship network of co-authors of Luisa Ojeda‐Fernández

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Ojeda‐Fernández. A scholar is included among the top collaborators of Luisa Ojeda‐Fernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Ojeda‐Fernández. Luisa Ojeda‐Fernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Succurro, Elena, Luisa Ojeda‐Fernández, Carlotta Franchi, et al.. (2025). Polypharmacy in older patients with diabetes mellitus: a population based-study of northern Italy. Acta Diabetologica. 62(11). 1929–1939.

Conti, Maria Vittoria, Ilaria Ardoino, Luisa Ojeda‐Fernández, et al.. (2025). Lights and Shadows of a Primary School-Based Nutrition Education Program in Italy: Insights from the LIVELY Project. Nutrients. 17(17). 2778–2778. 1 indexed citations

Ojeda‐Fernández, Luisa, G Torrigiani, Mauro Molteni, et al.. (2025). Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study. Clinical Research in Cardiology.

Zuin, Marco, Luisa Ojeda‐Fernández, G Torrigiani, & Matteo Bertini. (2024). Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysis. Heart Rhythm. 21(9). 1613–1620. 9 indexed citations

Foresta, Andreana, Luisa Ojeda‐Fernández, Mauro Tettamanti, et al.. (2024). Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients. Journal of Primary Care & Community Health. 15. 4277842524–4277842524.

Conti, Maria Vittoria, Ilaria Ardoino, Andreana Foresta, et al.. (2024). Multidimensional School-Based and Family-Involved Interventions to Promote a Healthy and Sustainable Lifestyle (LIVELY) for Childhood Obesity Prevention: Study Protocol. JMIR Research Protocols. 13. e57509–e57509. 3 indexed citations

Ojeda‐Fernández, Luisa, Marta Baviera, Andreana Foresta, et al.. (2023). Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy. Frontiers in Cardiovascular Medicine. 10. 1244002–1244002. 1 indexed citations

Foresta, Andreana, Luisa Ojeda‐Fernández, Maria Carla Roncaglioni, et al.. (2023). Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes. Clinical Therapeutics. 45(4). e115–e126. 6 indexed citations

Foresta, Andreana, Elena Succurro, Marta Baviera, et al.. (2023). Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy. Diabetes Research and Clinical Practice. 202. 110742–110742. 12 indexed citations

10.

Ojeda‐Fernández, Luisa, Andreana Foresta, Mauro Tettamanti, et al.. (2022). Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID ‐19 patients with diabetes: A population‐based study in Lombardy. Diabetes Obesity and Metabolism. 24(5). 891–898. 16 indexed citations

11.

Buonfrate, Dora, Davide Martini, Maria Carla Roncaglioni, et al.. (2022). High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial. International Journal of Antimicrobial Agents. 59(2). 106516–106516. 36 indexed citations

12.

Meessen, Jennifer, Giulia Cesaroni, Gian Francesco Mureddu, et al.. (2021). IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study. BMC Cardiovascular Disorders. 21(1). 328–328. 14 indexed citations

13.

Aristorena, Mikel, Eunate Gallardo‐Vara, Mateo de las Casas-Engel, et al.. (2019). MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells. International Journal of Molecular Sciences. 20(12). 3107–3107. 64 indexed citations

14.

Ojeda‐Fernández, Luisa, Lucía Recio-Poveda, Mikel Aristorena, et al.. (2016). Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response. PLoS Genetics. 12(3). e1005935–e1005935. 47 indexed citations

15.

Blanco, Francisco J., Luisa Ojeda‐Fernández, Mikel Aristorena, et al.. (2014). Genome‐Wide Transcriptional and Functional Analysis of Endoglin Isoforms in the Human Promonocytic Cell Line U937. Journal of Cellular Physiology. 230(4). 947–958. 14 indexed citations

16.

Aristorena, Mikel, Francisco J. Blanco, Mateo de las Casas-Engel, et al.. (2014). Expression of endoglin isoforms in the myeloid lineage and their role during aging and macrophage polarization. Journal of Cell Science. 127(Pt 12). 2723–35. 33 indexed citations

17.

Tabruyn, Sébastien P., Sylvain Hansen, Luisa Ojeda‐Fernández, et al.. (2013). MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. Angiogenesis. 16(4). 877–887. 27 indexed citations

18.

Fontalba, Ana, José L. Fernández-Luna, Roberto Zarrabeitia, et al.. (2013). Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1. BMC Medical Genetics. 14(1). 121–121. 6 indexed citations

19.

Ojeda‐Fernández, Luisa, Laura Barrios, Alicia Rodríguez‐Barbero, et al.. (2010). Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Clinica Chimica Acta. 411(7-8). 494–499. 21 indexed citations

20.

Fontalba, Ana, Africa Fernández-L, Virginia Albiñana, et al.. (2008). Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia. BMC Medical Genetics. 9(1). 75–75. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact